Energenesis Biomedical Co., Ltd. 6657

TWSE · Taiwan · Health Technology

TWD 32.90+0.30 (+0.92%)

Market closed· Oct 2, 2026, 5:30 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Energenesis Biomedical Co., Ltd. 6657

TWSE · Taiwan · Health Technology

TWD 32.90+0.30 (+0.92%)

Market closed· Oct 2, 2026, 5:30 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-19.16% · 6MFull-screen chart

Open TWD 32.20High TWD 32.90Low TWD 32.10Close TWD 32.90Volume 82.06K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: TWD 32.60
Day range: TWD 32.10 – TWD 32.90
52-week range: TWD 28.35 – TWD 59.70
Volume: 82.06K
Market cap: TWD 2.90B
Next earnings date: 2026-11-17
Avg. volume (1Y): 308.50K

Performance

1 week

+1.39%

1 month

+6.99%

3 months

-10.48%

6 months

-20.15%

Year to date

-19.85%

1 year

-37.92%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: Taiwan
Exchange: TWSE
Shares outstanding: 87.91M
Employees: 34
ISIN: TW0006657000
Beta: 0.25

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceAug 06, 2026

Energenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for ENERGI-F703DFU

Energenesis Biomedical Co., Ltd. (TWSE: 6657) today announced that it has entered into a joint development agreement with Taiwan Tanabe Seiyaku Co., Ltd. (Taiwan Tanabe), the wholly owned subsidiary of Tanabe Pharma Corporation, for ENERGI-F703DFU, Energenesis' investigational topical drug for diabetic foot ulcers (DFU).

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.